EPISODE · May 5, 2026 · 2 MIN
Neuronetics Q1 2026: Revenue Surges, Cost Cuts, and New Sales Models
from The Daily News Now! Business
Neuronetics Q1 2026 earnings show a 8% revenue increase to $34.5M, driven by a 15% jump in U.S. clinics revenue. NeuroStar system sales rose by 10% despite a 3% overall decline. Cost cuts and new sales models are expected to boost efficiency. Net losses narrowed to $10.8M, and cash flow is projected to turn positive in the second half. Guidance remains steady, with a focus on clinic efficiency, broader NeuroStar reach, and potential new therapies. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/4bd3581f6c07c84d
NOW PLAYING
Neuronetics Q1 2026: Revenue Surges, Cost Cuts, and New Sales Models
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m